Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers (BESAGE)

April 19, 2025 updated by: Rebecca Lee, Arizona State University
This study aims to get children safely back to school by (1) Child and Family Testing, (2) ECE Personnel Testing, and (3) Outdoor Learning via Garden Education.

Study Overview

Detailed Description

This study aims to get children safely back to school with a three strategy approach.

  1. Child and Family Testing. Investigators will determine acceptability, feasibility, efficacy and scalability of testing children and families as a pre-screening strategy for re-entry to 40 CACFP-eligible ECE sites for fall 2021. Our trained bilingual ASU team (vaccinated staff and nursing students) will provide onsite testing ECE sites. Investigators will assess acceptability and feasibility via brief parent surveys and developmentally appropriate icon ratings for children, and assess efficacy as the proportion of viable samples obtained, coaching time needed to obtain one sample, and proportion of successfully obtained samples. Investigators will document costs of delivering the screening strategy (e.g., personnel, time, materials) to determine scalability. For participants testing positive for COVID-19, community health workers from Equality Health Services will provide follow-up care.
  2. ECE Personnel Testing. Investigators will determine the acceptability, feasibility, efficacy and scalability of routine ECE screening of ECE personnel (teachers and aides) who have direct contact with children. Investigators will determine the acceptability of screening by 6-8 focus groups with teachers (N=80) from the 40 ECE sites above in July. Investigators will measure feasibility and efficacy (agree to test, proportion of viable samples obtained) of bi-weekly ECE site-based testing with school personnel from half (20) of the sites for fall 2021. Investigators will survey teachers to determine how acceptability toward testing relates to importance for back to ECE safety changes as vaccine uptake increases and vaccine hesitancy decreases over time. Investigators will record costs (e.g., personnel, time, materials) to determine scalability. Investigators will determine the additive efficacy of both child testing (see #1) and ECE personnel testing on attendance and enrollment. For participants testing positive for COVID-19, community health workers from Equality Health Services will provide follow-up care.
  3. Outdoor Learning via Garden Education. Investigators will determine the efficacy of enhanced outdoor learning opportunities for closing the gap from the lack of in person based ECE on motor development and eating in the absence of hunger in 4 and 5 year olds. Investigators will randomize participating sites to engage in an adapted Sustainability via Active Garden Education (SAGE) garden curriculum in Spring of 2022 or wait list. Wait list sites will receive the garden and curriculum in Fall 2022. Investigators will install or enhance existing gardens in ECE sites to promote outdoor learning opportunities linked to NAEYC guidelines, and expect children in those sites to gain more rapid improvements following the learning gap. Using established protocols Investigators will test children on motor behavior and eating in the absence of hunger in Fall of 2021 (T1, baseline), prior to implementing SAGE, in Spring 2022, following SAGE implementation, and then a follow up in Fall of 2022 to determine ongoing effects.

Study Type

Interventional

Enrollment (Actual)

1356

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Arizona State University-Downtown Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion

  • Adult parents and their minor children (age 3-5)
  • Children and their parents who are attending eligible early care and education (ECE) sites
  • ECE site personnel (adults 18 and older) with direct contact of children attending ECE sites.

Exclusion

-Children with health-compromising conditions (e.g., food allergies) that study activities might aggravate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CHILD testing
One child and parent dyad will be tested for COVID-19 using the ASU saliva test as part of back-to-ECE safely programming. All sites will receive this condition.
Preschool children and their parent will complete saliva COVID-19 tests at the start of the school year and after winter break as part of a back-to-ECE safely intervention. Tests may be completed during pick up, at drop off, or during school, depending on local on-campus regulations.
Experimental: CHILD+ personnel testing
This arm receives the CHILD condition plus ECE site personnel are screened biweekly for COVID-19 using the ASU saliva test.
Preschool children and their parent will complete saliva COVID-19 tests at the start of the school year and after winter break as part of a back-to-ECE safely intervention. Tests may be completed during pick up, at drop off, or during school, depending on local on-campus regulations.
ECE personnel will complete saliva COVID-19 tests biweekly through the school year as part of a back-to-ECE safely intervention. Tests may be completed on the ECE campus or in the parking lot, depending on local on-campus regulations
Experimental: SAGE garden
The SAGE arm is a garden-based curriculum that emphasizes outdoor learning opportunities such as active games, songs, and garden-activities. About half of the original 40 sites (roughly evenly divided by CHILD and CHILD+) will receive this in year one, and the remaining sites will receive this condition in year two.
Preschool children and their parent will complete saliva COVID-19 tests at the start of the school year and after winter break as part of a back-to-ECE safely intervention. Tests may be completed during pick up, at drop off, or during school, depending on local on-campus regulations.
ECE personnel will complete saliva COVID-19 tests biweekly through the school year as part of a back-to-ECE safely intervention. Tests may be completed on the ECE campus or in the parking lot, depending on local on-campus regulations
The SAGE garden programming includes installation of a garden; teacher training via Zoom and/or short videos, a binder and website support along with other accompanying materials and teacher technical support (email, text, phone); gardening supplies and gear (e.g., hats, watering cans, gloves); and delivers active songs, games, science experiments and other outdoor learning opportunities.
Sham Comparator: Wait list
Those in the wait list condition will receive SAGE in year two.
Preschool children and their parent will complete saliva COVID-19 tests at the start of the school year and after winter break as part of a back-to-ECE safely intervention. Tests may be completed during pick up, at drop off, or during school, depending on local on-campus regulations.
ECE personnel will complete saliva COVID-19 tests biweekly through the school year as part of a back-to-ECE safely intervention. Tests may be completed on the ECE campus or in the parking lot, depending on local on-campus regulations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Viable sample
Time Frame: Within six weeks from the start of school (varies by site and semester)
Proportion of viable saliva samples obtained from children
Within six weeks from the start of school (varies by site and semester)
Proportion of Children Attending ECE
Time Frame: within four weeks of the end of school (varies by site and semester)
Aggregated weekly attendance of children in ECE sites and comparison (non-participating) sites.
within four weeks of the end of school (varies by site and semester)
Progressive Aerobic Cardiovascular Endurance Run (PACER)
Time Frame: Baseline pre-intervention
Product-based quantitative, locomotor skills test
Baseline pre-intervention
Progressive Aerobic Cardiovascular Endurance Run (PACER)
Time Frame: Post-test up to four weeks after intervention
Product-based quantitative, locomotor skills test
Post-test up to four weeks after intervention
Children's Activity and Movement in Preschool Study (CHAMPS) motor skill protocol
Time Frame: Baseline pre-intervention
Process-based quantitative, locomotor skills test that tests skills of running, broad jumping, sliding, galloping, leaping, and hopping
Baseline pre-intervention
Children's Activity and Movement in Preschool Study (CHAMPS) motor skill protocol
Time Frame: Posttest up to four week post-intervention
Process-based quantitative, locomotor skills test that tests skills of running, broad jumping, sliding, galloping, leaping, and hopping
Posttest up to four week post-intervention
Eating in the absence of hunger
Time Frame: Baseline pre-intervention
Behavioral, quantitative test of eating when one is not hungry
Baseline pre-intervention
Eating in the absence of hunger
Time Frame: Posttest up to four weeks post-intervention
Behavioral, quantitative test of eating when one is not hungry
Posttest up to four weeks post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability and feasibility of saliva COVID-19 test
Time Frame: At time of COVID-19 test within six weeks from the start of school (varies by site and semester)
Self-report survey scale that measures difficulty, satisfaction and repeatability of COVID-19 test.
At time of COVID-19 test within six weeks from the start of school (varies by site and semester)
Cost to obtain a sample
Time Frame: Time 1 at the time of COVID-19 test, Within six weeks from the start of school (varies by site and semester)
Cost including personnel, time, materials, space to obtain a sample
Time 1 at the time of COVID-19 test, Within six weeks from the start of school (varies by site and semester)
Parent reports of COVID-19 household incidence
Time Frame: Approximately once per month following time 1, up to 10 months following time 1 (varies by site and semester)
Brief questionnaire that measures self-report of COVID-19 cases in households enrolled in the project completed by parents approximately once per month
Approximately once per month following time 1, up to 10 months following time 1 (varies by site and semester)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographics
Time Frame: Time 1 Baseline start of the semester
Tier 1 Common Data Element (PhenX Toolkit): Age (Demo), Annual Family Income (Demo), Employment Status (Demo), Educational Attainment (Demo), Gender (Demo), Ethnicity/Race (Demo), Health Insurance Coverage (Demo)
Time 1 Baseline start of the semester
Vulnerability and Exposure to COVID-19 and Vaccine Acceptance
Time Frame: Time 1 Baseline start of the semester
RADx-UP measure from the PhenX Toolkit of Vulnerability and Exposure to COVID-19 and Vaccine Acceptance
Time 1 Baseline start of the semester

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rebecca Lee, PhD, Arizona State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 22, 2021

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

July 28, 2021

First Submitted That Met QC Criteria

January 3, 2022

First Posted (Actual)

January 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 24, 2025

Last Update Submitted That Met QC Criteria

April 19, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All de-identified data is to be shared with the RADx-UP CDCC per the DTA.

IPD Sharing Time Frame

Data will be available through the RADx-UP CDCC per their governing principles.

IPD Sharing Access Criteria

Access is through the RADx-UP CDCC.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on CHILD back-to-ECE COVID-19 saliva testing

Subscribe